Giant Biogene Holding Co., Ltd.
2367.HKFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
720
Cost of Revenue
129
Gross Profit
591
Gross Margin
82.1%
Operating Income
300
Operating Margin
41.7%
Net Income
268
Net Margin
37.2%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
300
EBITDA Margin
41.7%
2023
12/31/2023
Revenue
458
Cost of Revenue
75
Gross Profit
383
Gross Margin
83.6%
Operating Income
216
Operating Margin
47.2%
Net Income
189
Net Margin
41.2%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
231
EBITDA Margin
50.5%
2022
12/31/2022
Revenue
307
Cost of Revenue
48
Gross Profit
259
Gross Margin
84.4%
Operating Income
147
Operating Margin
47.9%
Net Income
130
Net Margin
42.4%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
157
EBITDA Margin
51.0%
2021
12/31/2021
Revenue
202
Cost of Revenue
26
Gross Profit
176
Gross Margin
87.2%
Operating Income
119
Operating Margin
58.9%
Net Income
108
Net Margin
53.3%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
121
EBITDA Margin
60.1%
2020
12/31/2020
Revenue
155
Cost of Revenue
24
Gross Profit
131
Gross Margin
84.6%
Operating Income
105
Operating Margin
67.8%
Net Income
107
Net Margin
69.4%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
107
EBITDA Margin
69.4%